RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
13.05
-0.09 (-0.68%)
At close: Jul 3, 2025, 1:00 PM
13.70
+0.65 (4.98%)
After-hours: Jul 3, 2025, 3:59 PM EDT
RxSight Market Cap
RxSight has a market cap or net worth of $530.31 million as of July 3, 2025. Its market cap has decreased by -75.75% in one year.
Market Cap
530.31M
Enterprise Value
313.01M
1-Year Change
-75.75%
Ranking
Category
Stock Price
$13.05
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has increased from $424.33M to $530.31M, an increase of 24.98%. That is a compound annual growth rate of 5.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 530.31M | -61.73% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |